
EAU 2021

Read the full Report (pdf)

Featured articles


EAU TV: The best on bladder cancer and renal cell carcinoma

EAU TV: Robotic surgery and advanced prostate cancer
CONTENTS
Online First
LUTS & BPH

Best of EAU: The surgical armamentarium is evolving
IPSS: Visual alternatives to aid comprehension and new risk prediction models
Urinary Tract Infections
Prophylactic treatments for recurrent urinary tract infections
Failure of conservative management in emphysematous pyelonephritis
Antibiotic treatment of healthcare-associated infections
Prostate Cancer

EAU TV: Robotic surgery and advanced prostate cancer

EAU TV: The best on prostate cancer and incontinence & andrology
Best of EAU: Updates on imaging and treatment of prostate cancer

Radiographic PFS benefit of adding abiraterone to ADT and docetaxel in mCSPC
177Lu-PSMA-617: A new class of effective therapy
Testis and Penile Cancer
Best of EAU: New advances in testicular and penile cancer
Recommendations for the management of indeterminate small testis masses
Residual tumour resection in case of elevated markers
Bladder Cancer

EAU TV: The best on bladder cancer and renal cell carcinoma
Best of EAU: Highlights on bladder cancer
ctDNA can guide adjuvant immunotherapy in muscle-invasive bladder cancer
Durvalumab ± tremelimumab by cisplatin eligibility in metastatic urothelial carcinoma
Circulating tumour cells could aid in the decision to give neoadjuvant chemotherapy
Renal Cancer

EAU TV: The best on bladder cancer and renal cell carcinoma
Best of EAU: Immune cell populations have prognostic value in RCC
